Opko Health Valuation
| OPK Stock | USD 1.24 0.03 2.48% |
Today, the company appears to be undervalued. Opko Health holds a recent Real Value of $1.81 per share. The prevailing price of the company is $1.24. Our model determines the value of Opko Health from analyzing the company fundamentals such as Operating Margin of (0.35) %, shares outstanding of 767.7 M, and Return On Equity of -0.13 as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Opko Health's valuation include:
Price Book 0.7351 | Enterprise Value | Enterprise Value Ebitda 20.7904 | Price Sales 1.5454 | Forward PE 64.5161 |
Undervalued
Today
Please note that Opko Health's price fluctuation is unstable at this time. Calculation of the real value of Opko Health is based on 3 months time horizon. Increasing Opko Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Opko Health's intrinsic value may or may not be the same as its current market price of 1.24, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.24 | Real 1.81 | Target 3.56 | Hype 1.21 |
The intrinsic value of Opko Health's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Opko Health's stock price.
Estimating the potential upside or downside of Opko Health helps investors to forecast how Opko stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Opko Health more accurately as focusing exclusively on Opko Health's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Opko Health's intrinsic value based on its ongoing forecasts of Opko Health's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Opko Health's closest peers.
Opko Health Cash |
|
Opko Health Total Value Analysis
Opko Health is now projected to have company total value of 939.85 M with market capitalization of 992.23 M, debt of 504.44 M, and cash on hands of 210.46 M. Please note that company total value may be misleading and is a subject to accounting gimmicks. We encourage investors to carefully check all of the Opko Health fundamentals before making security assessment based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
939.85 M | 992.23 M | 504.44 M | 210.46 M |
Opko Health Investor Information
About 49.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.74. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Opko Health recorded a loss per share of 0.24. The entity had not issued any dividends in recent years. Opko Health is not in a good financial situation at this time. It has a very high odds of going through financial crisis in March.Opko Health Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Opko Health has an asset utilization ratio of 32.41 percent. This suggests that the Company is making $0.32 for each dollar of assets. An increasing asset utilization means that Opko Health is more efficient with each dollar of assets it utilizes for everyday operations.Opko Health Profitability Analysis
Considering the key profitability indicators obtained from Opko Health's historical financial statements, Opko Health may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in March. Profitability indicators assess Opko Health's ability to earn profits and add value for shareholders.Net Loss | First Reported 1996-03-31 | Previous Quarter -148.4 M | Current Value 61.2 M | Quarterly Volatility 50 M |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.54 | 0.5 |
|
|
For Opko Health profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Opko Health to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Opko Health utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Opko Health's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Opko Health over time as well as its relative position and ranking within its peers.
Opko Health Earnings per Share Projection vs Actual
By analyzing Opko Health's earnings estimates, investors can diagnose different trends across Opko Health's analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Opko Health is based on EPS before non-recurring items and includes expenses related to employee stock options.Opko Health Ownership Allocation
Opko Health owns a total of 767.7 Million outstanding shares. Opko Health has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.Opko Health Profitability Analysis
The company reported the last year's revenue of 713.14 M. Reported Net Loss for the year was (53.22 M) with profit before taxes, overhead, and interest of 121.55 M.About Opko Health Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Opko Health. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Opko Health based exclusively on its fundamental and basic technical indicators. By analyzing Opko Health's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Opko Health's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Opko Health. We calculate exposure to Opko Health's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Opko Health's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 357.7 M | 375.6 M | |
| Pretax Profit Margin | (0.01) | (0.01) | |
| Operating Profit Margin | (0.19) | (0.20) | |
| Net Loss | (0.07) | (0.07) | |
| Gross Profit Margin | 0.50 | 0.54 |
Opko Health Growth Indicators
Investing in growth stocks can be very risky. If the company such as Opko Health does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 694 M | |
| Quarterly Earnings Growth Y O Y | -0.126 | |
| Forward Price Earnings | 64.5161 |
Opko Health Current Valuation Indicators
Opko Health's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Opko Health's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Opko Health, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Opko Health's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Opko Health's worth.When determining whether Opko Health is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Opko Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Opko Health Stock. Highlighted below are key reports to facilitate an investment decision about Opko Health Stock: Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Opko Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation. For more information on how to buy Opko Stock please use our How to buy in Opko Stock guide.You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Opko Health. Anticipated expansion of Opko directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Opko Health assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth (0.13) | Earnings Share (0.24) | Revenue Per Share | Return On Assets | Return On Equity |
The market value of Opko Health is measured differently than its book value, which is the value of Opko that is recorded on the company's balance sheet. Investors also form their own opinion of Opko Health's value that differs from its market value or its book value, called intrinsic value, which is Opko Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Opko Health's market value can be influenced by many factors that don't directly affect Opko Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Opko Health's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Opko Health should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Opko Health's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.